Myriad Genetics, Inc. (MYGN)
NASDAQ: MYGN · Real-Time Price · USD
3.650
+0.070 (1.96%)
May 18, 2026, 4:00 PM EDT - Market closed

Myriad Genetics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
May '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
3455751,2521,7211,1782,208
Market Cap Growth
-50.06%-54.06%-27.26%46.04%-46.64%48.12%
Enterprise Value
431.84628.331,2771,7161,1941,949
Last Close Price
3.656.1513.7119.1414.5127.60
PE Ratio
--1.56-9.72-6.02-10.44-78.86
Forward PE
29.01196.49141.34---
PS Ratio
0.420.701.492.281.743.20
PB Ratio
1.021.561.792.201.332.28
P/TBV Ratio
1.011.551.772.021.322.22
P/FCF Ratio
--41.67-45.19-9.88-7.773680.00
P/OCF Ratio
143.64319.46-143.88-15.52-11.08118.71
EV/Sales Ratio
0.520.761.522.281.762.82
EV/EBITDA Ratio
--1.88-20.49-8.78-13.59-15.26
EV/EBIT Ratio
--1.62-10.34-6.67-8.49-10.23
EV/FCF Ratio
--45.53-46.09-9.85-7.883247.50
Debt / Equity Ratio
0.610.550.180.170.150.08
Debt / EBITDA Ratio
-0.63-0.63-2.25-0.78-1.65-0.72
Debt / FCF Ratio
-15.90-15.20-5.07-0.87-0.96153.83
Net Debt / Equity Ratio
0.260.160.050.010.03-0.25
Net Debt / EBITDA Ratio
-0.26-0.18-0.61-0.06-0.341.93
Net Debt / FCF Ratio
-6.55-4.36-1.37-0.06-0.20-410.83
Asset Turnover
1.200.950.770.640.540.50
Inventory Turnover
8.518.5310.1911.2211.419.32
Quick Ratio
1.911.981.361.641.582.11
Current Ratio
2.402.491.822.012.002.37
Return on Equity (ROE)
-113.38%-68.45%-17.15%-31.55%-12.08%-2.94%
Return on Assets (ROA)
-56.36%-41.35%-11.71%-22.04%-8.89%-6.63%
Return on Invested Capital (ROIC)
-90.86%-59.57%-15.53%-28.30%-12.79%-9.26%
Return on Capital Employed (ROCE)
-69.68%-53.92%-13.32%-25.09%-12.91%-15.95%
Earnings Yield
-116.00%-64.23%-10.28%-16.61%-9.58%-1.27%
FCF Yield
-3.86%-2.40%-2.21%-10.12%-12.87%0.03%
Buyback Yield / Dilution
-2.42%-2.21%-9.42%-2.73%-3.33%-4.28%
Total Shareholder Return
-2.42%-2.21%-9.42%-2.73%-3.33%-4.28%
Updated May 6, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q